Product Name: Icotinib HCl featured
Description: Icotinib, also known as BPI-2009, is an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Icotinib selectively inhibits the wild-type and several mutated forms of EGFR tyrosine
CAS NO: 1429651-50-2 Product: HPOB
Synonym: BPI2009; BPI 2009; BPI-2009; Icotinib; Brand name: Conmana.
IUPAC Chemical Name: N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine hydrochloride
In ChiKey: PNNGXMJMUUJHAV-UHFFFAOYSA-NCRM1 inhibitors
SMILE Code: C#CC1=CC(NC2=C3C=C(OCCOCCOCCO4)C4=CC3=NC=N2)=CC=C1.[H]Cl
Appearance: Light yellow solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Web Site：Medchemexpress
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22127230
Chemical Formula：C22H22ClN3O4
ExactMass:
Molecular Weight: 427.89
Elemental Analysis: C, 61.76; H, 5.18; Cl, 8.28; N, 9.82; O, 14.96
bet-bromodomain.com
BET Bromodomain Inhibitor
